About NAB DUTAXEL (PACLITAXEL PROTEIN BOUND)
NAB DUTAXEL (Paclitaxel Protein Bound) is a hot-selling, kingly solution for the treatment of breast, non-small cell lung, and pancreatic cancers. This reduced-risk, Rx-only formulation features protein bound particles, enabling extraordinary efficacy and precision. Each towering 100 mg single-dose vial offers a popular and modern approach to intravenous therapy for adult patients. Trusted by leading exporters, suppliers, and traders across India, NAB DUTAXEL ensures optimal clinical outcomes and quality, making it an exceptional choice for oncologists and healthcare institutions.
Versatile Applications and Target Areas
NAB DUTAXEL offers extraordinary flexibility for intravenous use in the treatment of various cancers such as breast, non-small cell lung, and pancreatic tumors. Its broad spectrum covers hospitals, specialty cancer clinics, and outpatient infusion centers. This hot-selling injectable suspension can be administered at any accredited healthcare facility where intravenous chemotherapy is standard, making it highly adaptable to the diverse surface and areas of medical application.
Payment, Sample, and Shipment Details
Supplying NAB DUTAXEL is streamlined for convenience. Packing & dispatch processes ensure the safe shipment of vials, with packing designed for secure transport from India. Flexible payment terms accommodate institutional needs, and sample vials are available for initial evaluation. The primary FOB port is India, supporting both domestic and international delivery requirements. Each shipment is handled with utmost care, reflecting NAB DUTAXEL's commitment to quality and timely supply.
FAQ's of NAB DUTAXEL (PACLITAXEL PROTEIN BOUND):
Q: How is NAB DUTAXEL (Paclitaxel Protein Bound) administered?
A: NAB DUTAXEL is administered as an intravenous infusion and should only be given by healthcare professionals in a clinical setting.
Q: What are the main indications for using NAB DUTAXEL?
A: This injectable suspension is indicated for the treatment of adults with breast cancer, non-small cell lung cancer, and pancreatic cancer.
Q: When should NAB DUTAXEL be stored and checked for expiry?
A: The vials must be stored below 25C and healthcare personnel should always check the pack for expiry prior to administration.
Q: Where can NAB DUTAXEL be applied?
A: NAB DUTAXEL is suitable for hospitals, cancer specialty clinics, and outpatient infusion centers where intravenous chemotherapy is administered.
Q: What is the benefit of the protein-bound formulation of NAB DUTAXEL?
A: The protein-bound formulation of NAB DUTAXEL allows for enhanced delivery of paclitaxel to cancer cells, improving therapeutic effects and reducing certain risks associated with traditional forms.
Q: How is NAB DUTAXEL supplied and shipped to buyers?
A: NAB DUTAXEL is supplied as a single-dose vial in packs, dispatched securely from India and shipped through designated FOB ports to meet clients' supply chain preferences.